453 related articles for article (PubMed ID: 29246759)
1. Metabolic Control of CD8
Zhang L; Romero P
Trends Mol Med; 2018 Jan; 24(1):30-48. PubMed ID: 29246759
[TBL] [Abstract][Full Text] [Related]
2. Genetic Regulation of Fate Decisions in Therapeutic T Cells to Enhance Tumor Protection and Memory Formation.
Veliça P; Zech M; Henson S; Holler A; Manzo T; Pike R; Santos E Sousa P; Zhang L; Heinz N; Schiedlmeier B; Pule M; Stauss H; Chakraverty R
Cancer Res; 2015 Jul; 75(13):2641-52. PubMed ID: 25904681
[TBL] [Abstract][Full Text] [Related]
3. Metabolic Control of Epigenetics and Its Role in CD8
Yerinde C; Siegmund B; Glauben R; Weidinger C
Front Immunol; 2019; 10():2718. PubMed ID: 31849941
[TBL] [Abstract][Full Text] [Related]
4. Reinforce the antitumor activity of CD8
Nabe S; Yamada T; Suzuki J; Toriyama K; Yasuoka T; Kuwahara M; Shiraishi A; Takenaka K; Yasukawa M; Yamashita M
Cancer Sci; 2018 Dec; 109(12):3737-3750. PubMed ID: 30302856
[TBL] [Abstract][Full Text] [Related]
5. Rapamycin Impairs Antitumor CD8+ T-cell Responses and Vaccine-Induced Tumor Eradication.
Chaoul N; Fayolle C; Desrues B; Oberkampf M; Tang A; Ladant D; Leclerc C
Cancer Res; 2015 Aug; 75(16):3279-91. PubMed ID: 26122844
[TBL] [Abstract][Full Text] [Related]
6. Emerging concepts of T cell metabolism as a target of immunotherapy.
Chang CH; Pearce EL
Nat Immunol; 2016 Apr; 17(4):364-8. PubMed ID: 27002844
[TBL] [Abstract][Full Text] [Related]
7. Cell-Intrinsic Barriers of T Cell-Based Immunotherapy.
Ghoneim HE; Zamora AE; Thomas PG; Youngblood BA
Trends Mol Med; 2016 Dec; 22(12):1000-1011. PubMed ID: 27825667
[TBL] [Abstract][Full Text] [Related]
8. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy.
Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S
Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878
[TBL] [Abstract][Full Text] [Related]
9. Effector, Memory, and Dysfunctional CD8(+) T Cell Fates in the Antitumor Immune Response.
Reiser J; Banerjee A
J Immunol Res; 2016; 2016():8941260. PubMed ID: 27314056
[TBL] [Abstract][Full Text] [Related]
10. Aptamer-Targeted Attenuation of IL-2 Signaling in CD8
Rajagopalan A; Berezhnoy A; Schrand B; Puplampu-Dove Y; Gilboa E
Mol Ther; 2017 Jan; 25(1):54-61. PubMed ID: 28129128
[TBL] [Abstract][Full Text] [Related]
11. The Roles of CD8
St Paul M; Ohashi PS
Trends Cell Biol; 2020 Sep; 30(9):695-704. PubMed ID: 32624246
[TBL] [Abstract][Full Text] [Related]
12. mTORC1 and mTORC2 selectively regulate CD8⁺ T cell differentiation.
Pollizzi KN; Patel CH; Sun IH; Oh MH; Waickman AT; Wen J; Delgoffe GM; Powell JD
J Clin Invest; 2015 May; 125(5):2090-108. PubMed ID: 25893604
[TBL] [Abstract][Full Text] [Related]
13. Generating stem-like memory T cells with antioxidants for adoptive cell transfer immunotherapy of cancer.
Pilipow K; Scamardella E; Lugli E
Methods Enzymol; 2020; 631():137-158. PubMed ID: 31948545
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide fitness gene identification reveals Roquin as a potent suppressor of CD8 T cell expansion and anti-tumor immunity.
Zhao H; Liu Y; Wang L; Jin G; Zhao X; Xu J; Zhang G; Ma Y; Yin N; Peng M
Cell Rep; 2021 Dec; 37(10):110083. PubMed ID: 34879274
[TBL] [Abstract][Full Text] [Related]
15. Uncoupling protein 2 regulates metabolic reprogramming and fate of antigen-stimulated CD8+ T cells.
Chaudhuri L; Srivastava RK; Kos F; Shrikant PA
Cancer Immunol Immunother; 2016 Jul; 65(7):869-74. PubMed ID: 27271549
[TBL] [Abstract][Full Text] [Related]
16. Creatine uptake regulates CD8 T cell antitumor immunity.
Di Biase S; Ma X; Wang X; Yu J; Wang YC; Smith DJ; Zhou Y; Li Z; Kim YJ; Clarke N; To A; Yang L
J Exp Med; 2019 Dec; 216(12):2869-2882. PubMed ID: 31628186
[TBL] [Abstract][Full Text] [Related]
17. The tumor microenvironment shapes the molecular characteristics of exhausted CD8
Cheng H; Ma K; Zhang L; Li G
Cancer Lett; 2021 May; 506():55-66. PubMed ID: 33662493
[TBL] [Abstract][Full Text] [Related]
18. Metabolic Regulation of T Cell Longevity and Function in Tumor Immunotherapy.
Kishton RJ; Sukumar M; Restifo NP
Cell Metab; 2017 Jul; 26(1):94-109. PubMed ID: 28683298
[TBL] [Abstract][Full Text] [Related]
19. Microenvironment-driven metabolic adaptations guiding CD8
Park J; Hsueh PC; Li Z; Ho PC
Immunity; 2023 Jan; 56(1):32-42. PubMed ID: 36630916
[TBL] [Abstract][Full Text] [Related]
20. CD8+ T-cell exhaustion in cancer: mechanisms and new area for cancer immunotherapy.
He QF; Xu Y; Li J; Huang ZM; Li XH; Wang X
Brief Funct Genomics; 2019 Mar; 18(2):99-106. PubMed ID: 29554204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
